Overview
Robert Reid is a Hematologist and an Oncologist in Fairfax, Virginia. Dr. Reid is rated as an Advanced provider by MediFind in the treatment of Menopause. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Breast Cancer, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.
His clinical research consists of co-authoring 65 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 12 articles in the study of Menopause.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
Locations
Additional Areas of Focus
Dr. Reid has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Skip Viragh Outpatient Cancer Center
Dr. Visvanathan is a Professor on faculty at Johns Hopkins. She is a practicing medical oncologist and cancer epidemiologist focused on translating discoveries to the clinic and population as a whole. She directs the Clinical Cancer Genetics and Prevention service at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center (SKCCC) and is an active member of the Breast and Ovarian Program and Cancer Prevention and Control Program. Dr. Visvanathan is also Director of the Cancer Epidemiology Track in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health. With her research centered on primary and secondary prevention of breast and ovarian cancer, her goal is to reduce the incidence of and mortality from breast cancer globally by conducting impactful studies at the local, national, and international levels. Specifically, she focuses on the identification of atrisk groups, potential biomarkers of risk and prognosis and evaluation of preventive agents across the continuum. She conducts both observational studies and early phase clinical trials. She also teaches and mentors the next generation of clinicians and cancer researchers. Dr. Visvanathan has also served on national committees focused on Breast Cancer Risk Reduction, Breast Cancer Genetics and Cancer Disparities. She has also co-chaired National Guidelines on Breast Cancer Endocrine Prevention. Locally, serving on the Maryland State Cancer Council. Dr. Visvanathan received her medical degree from the University of Sydney in Australia. She subsequently went on to complete training in internal medicine and medical oncology, including a period as chief resident at Royal Prince Alfred Hospital. She then did further training in Medical Oncology at Johns Hopkins and also obtained a master’s degree in clinical/cancer epidemiology at Johns Hopkins Bloomberg School of Public Health. This was followed by a postdoctoral fellow before coming on to faculty in both the Johns Hopkins School of Medicine and Bloomberg School of Public Health. Dr. Visvanathan is rated as a Distinguished provider by MediFind in the treatment of Menopause. Her top areas of expertise are Breast Cancer, Ovarian Cancer, Menopause, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.
Lori Minasian is an Oncologist in Bethesda, Maryland. Dr. Minasian is rated as an Advanced provider by MediFind in the treatment of Menopause. Her top areas of expertise are Ovarian Cancer, Breast Cancer, Triple-Negative Breast Cancer, and Menopause.
Luminis Health Medical Group, LLC
Young Lee is a Hematologist Oncology specialist and a Hematologist in Annapolis, Maryland. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Menopause. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Hormone Replacement Therapy (HRT), and Splenectomy. Dr. Lee is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Reid isDistinguished. Learn about Breast Cancer.
- Lung CancerDr. Reid isDistinguished. Learn about Lung Cancer.
- Multiple MyelomaDr. Reid isDistinguished. Learn about Multiple Myeloma.
- Paget Disease of the BreastDr. Reid isDistinguished. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Reid isDistinguished. Learn about Pleuropulmonary Blastoma.
- Waldenstrom MacroglobulinemiaDr. Reid isDistinguished. Learn about Waldenstrom Macroglobulinemia.
- Advanced
- Adult Immune ThrombocytopeniaDr. Reid isAdvanced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Reid isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Anal CancerDr. Reid isAdvanced. Learn about Anal Cancer.
- Childhood Acute Myeloid Leukemia
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Reid isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Reid isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaDr. Reid isExperienced. Learn about Acute Promyelocytic Leukemia.
- AgranulocytosisDr. Reid isExperienced. Learn about Agranulocytosis.
